Conditional survival in patients with unresectable perihilar cholangiocarcinoma

被引:17
|
作者
Gaspersz, Marcia P. [1 ]
Buettner, Stefan [1 ]
van Vugt, Jeroen L. A. [1 ]
Roos, Eva [2 ]
Coelen, Robert J. S. [2 ]
Vugts, Jaynee [1 ]
Belt, Eric J. [3 ]
de Jonge, Jeroen [1 ]
Polak, Wojciech G. [1 ]
Willemssen, Francois E. J. A. [4 ]
van Gulik, Thomas M. [2 ]
IJzermans, Jan N. M. [1 ]
Koerkamp, Bas Groot [1 ]
机构
[1] Erasmus MC Univ, Med Ctr, Dept Surg, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands
[2] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands
[3] Albert Schweitzer Hosp, Dept Surg, Dordrecht, Netherlands
[4] Erasmus MC Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands
关键词
LONG-TERM SURVIVAL; HILAR CHOLANGIOCARCINOMA; BILIARY DRAINAGE; INTRAHEPATIC CHOLANGIOCARCINOMA; MULTIINSTITUTIONAL ANALYSIS; SURGICAL RESECTION; LIVER RESECTION; STAGING SYSTEM; CANCER; PROBABILITY;
D O I
10.1016/j.hpb.2017.07.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Conditional survival is the life expectancy from a point in time for a patient who has survived a specific period after presentation. The aim of the study was to estimate conditional survival for patients with unresectable perihilar cholangiocarcinoma. Methods: Patients with unresectable perihilar cholangiocarcinoma from two academic hospitals in the Netherlands between 2002 and 2012 were assessed. A multivariable Cox proportional hazards analysis was performed to identify risk factors associated with overall survival. Survival was estimated using the Kaplan-Meier method to evaluate factors associated with overall survival. Results: In total, 572 patients were included. Overall survival was 42% at one year and 6% at three years. The conditional chance of surviving three years was 15% at 1 year and increased to 38% at 2 years. Independent poor prognostic factors for overall survival were age >= 65 years, tumor size >3 cm on imaging, bilirubin levels (> 250 mmol/L), CA19-9 level at presentation (> 1000 U/ml), and suspected distant metastases on imaging. The conditional survival of patients with and without these prognostic factors was comparable after patients survived the first two or more years. Conclusion: The conditional chance of surviving for patients with unresectable perihilar cholangiocarcinoma increases with time. Poor prognostic factors become less relevant once patients have survived two years.
引用
收藏
页码:966 / 971
页数:6
相关论文
共 50 条
  • [1] Survival after Liver Transplantation in Patients with unresectable perihilar Cholangiocarcinoma
    Manekeller, Steffen
    [J]. ZENTRALBLATT FUR CHIRURGIE, 2021, 146 (02): : 154 - 154
  • [2] Endobiliary Ablation Improves Survival in Patients With Unresectable Perihilar Cholangiocarcinoma Compared to Stenting Alone
    Buerlein, Ross C. D.
    Strand, Daniel S.
    Uppal, Dushant S.
    Patrie, James T.
    Sauer, Bryan G.
    Shami, Vanessa M.
    Scheiman, James M.
    Zaydfudim, Victor M.
    Bauer, Todd W.
    Adams, Reid B.
    Wang, Andrew Y.
    [J]. TECHNIQUES AND INNOVATIONS IN GASTROINTESTINAL ENDOSCOPY, 2022, 24 (03): : 226 - 233
  • [3] Liver transplantation for unresectable perihilar cholangiocarcinoma
    Heimbach, JK
    Gores, GJ
    Haddock, MG
    Alberts, SR
    Nyberg, SL
    Ishitani, MB
    Rosen, CB
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 (02) : 201 - 207
  • [5] Unresectable Perihilar Cholangiocarcinoma: Multimodal Palliative Treatment
    Mosconi, Cristina
    Renzulli, Matteo
    Giampalma, Emanuela
    Galuppi, Andrea
    Balacchi, Caterina
    Brandi, Giovanni
    Ercolani, Giorgio
    Bianchi, Giampaolo
    Golfieri, Rita
    [J]. ANTICANCER RESEARCH, 2013, 33 (06) : 2747 - 2753
  • [6] Impact of EUS in liver transplantation workup for patients with unresectable perihilar cholangiocarcinoma
    de Jong, David M.
    den Hoed, Caroline M.
    Willemssen, Francois E. J. A.
    Thomeer, Maarten G. J.
    Bruno, Marco J.
    Koerkamp, Bas Groot
    de Jonge, Jeroen
    Alwayn, Ian P. J.
    van Hooft, Jeanin E.
    Hoogwater, Frederik
    Heide, Frans van der
    Inderson, Akin
    van Vilsteren, Frederike G. I.
    van Driel, Lydi M. J. W.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2024, 99 (04) : 548 - 556
  • [7] Perihilar cholangiocarcinoma resection: Is it beneficial for survival in elderly patients?
    Yu, Min
    Lu, Lina
    Wu, Rongjin
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (07): : 691 - 701
  • [8] THE SURVIVAL BENEFIT OF COMBINING NEOADJUVANT THERAPY WITH LIVER TRANSPLANTATION FOR PATIENTS WITH UNRESECTABLE PERIHILAR CHOLANGIOCARCINOMA - A SYSTEMATIC REVIEW AND SURVIVAL-ANALYSIS
    Dongelmans, Edo
    van Hoek, Joeri
    Domagala, Piotr
    Darwish-Murad, Sarwa
    Bennet, William
    Polak, Wojciech
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 286 - 286
  • [9] ERCP-DIRECTED BILIARY ABLATION PROLONGS SURVIVAL IN PATIENTS WITH UNRESECTABLE PERIHILAR CHOLANGIOCARCINOMA COMPARED TO STENTING ALONE
    Buerlein, Ross
    Strand, Daniel S.
    Patrie, James T.
    Sauer, Bryan G.
    Shami, Vanessa M.
    Scheiman, James M.
    Zaydfudim, Victor M.
    Bauer, Todd W.
    Adams, Reid B.
    Wang, Andrew Y.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB91 - AB92
  • [10] LIVER TRANSPLANTATION FOR UNRESECTABLE PERIHILAR CHOLANGIOCARCINOMA: AN ITALIAN SURVEY
    Gringeri, Enrico
    Furlanetto, Alessandro
    Lanari, Jacopo
    De Carlis, Luciano
    Mazzaferro, Vincenzo
    Romagnoli, Renato
    Cescon, Matteo
    Vivarelli, Marco
    De Simone, Paolo
    Rossi, Giorgio
    D'amico, Francesco Enrico
    Gruttadauria, Salvatore
    Cardillo, Massimo
    Boggi, Ugo
    Cillo, Umberto
    [J]. TRANSPLANT INTERNATIONAL, 2021, 34 : 13 - 13